Global Bio-chem Technology Group Co. Ltd. (HK:0809)
:0809
Top Page
Global Bio-chem Technology Group Co. Ltd.
(0809)
Select Model
Select Model
Rating:42Neutral
Price Target:
HK$0.06
▼(-3.33% Downside)
Action:ReiteratedDate:02/03/26
The score is held down primarily by severe financial instability (negative equity, high leverage, and ongoing profitability issues). Technicals add further pressure with the stock trading below major moving averages and negative MACD. Valuation looks inexpensive on P/E, but the low multiple likely reflects the underlying balance-sheet and earnings risk.
Positive Factors
Revenue Growth
A 42% reported revenue increase reflects expanding sales and market traction in core corn-processing products. Sustained top-line growth can support scale economies, help absorb fixed costs, and provide a base for margin recovery if product mix and utilization remain favorable.
Negative Factors
Balance Sheet Insolvency
Negative equity signals entrenched balance-sheet distress and excessive leverage, constraining the company’s ability to raise capital, negotiate supplier or creditor terms, and invest for growth. Over the medium term this elevates default risk and limits strategic flexibility.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
A 42% reported revenue increase reflects expanding sales and market traction in core corn-processing products. Sustained top-line growth can support scale economies, help absorb fixed costs, and provide a base for margin recovery if product mix and utilization remain favorable.
Read all positive factors
Global Bio-chem Technology Group Co. Ltd. (0809) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$1.01B
Dividend YieldN/A
Average Volume (3M)8.43M
Price to Earnings (P/E)―
Beta (1Y)-0.12
Revenue Growth42.14%
EPS Growth-81.25%
CountryHK
Employees1,567
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)-0.02
Shares Outstanding16,832,771,000
10 Day Avg. Volume3,078,640
30 Day Avg. Volume8,433,551
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)-0.48
Price to Sales (P/S)0.47
P/FCF Ratio12.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Global Bio-chem Technology Group Co. Ltd. Business Overview & Revenue Model
Company Description
Global Bio-chem Technology Group Company Limited, an investment holding company, manufactures and sells corn refined products and corn-based biochemical products in the People's Republic of China, rest of Asia, the Americas, and internationally. I...
How the Company Makes Money
Global Bio-chem Technology Group Co. Ltd. generates revenue through the sale of its bio-based products and chemicals to various industrial sectors. The company has established a diversified revenue model that includes direct sales of its core prod...
Global Bio-chem Technology Group Co. Ltd. Financial Statement Overview
Summary
Income Statement
40
Negative
Balance Sheet
20
Very Negative
Cash Flow
30
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.29B | 2.00B | 1.37B | 12.71M | 746.55M | 848.87M |
| Gross Profit | 313.85M | 218.68M | 43.64M | -263.37M | 48.35M | 74.10M |
| EBITDA | 104.98M | 16.85M | 4.69B | -469.06M | 785.63M | -1.39B |
| Net Income | 772.61M | 769.60M | 4.22B | -1.44B | -400.80M | -2.43B |
Balance Sheet | ||||||
| Total Assets | 4.69B | 4.54B | 5.21B | 5.85B | 6.48B | 7.60B |
| Cash, Cash Equivalents and Short-Term Investments | 221.55M | 85.47M | 315.41M | 41.77M | 109.13M | 153.32M |
| Total Debt | 3.60B | 3.69B | 5.45B | 8.91B | 8.44B | 8.96B |
| Total Liabilities | 6.89B | 6.50B | 9.25B | 13.64B | 13.18B | 13.62B |
| Stockholders Equity | -2.21B | -1.95B | -4.04B | -7.54B | -6.52B | -5.86B |
Cash Flow | ||||||
| Free Cash Flow | 64.48M | 76.04M | -94.24M | -94.19M | -501.02M | -43.02M |
| Operating Cash Flow | 67.68M | 76.04M | -50.46M | -88.01M | -475.21M | -26.19M |
| Investing Cash Flow | -3.74M | -535.00K | -14.37M | -413.00K | 392.59M | 120.09M |
| Financing Cash Flow | 29.89M | -76.06M | 112.62M | 109.75M | -48.66M | -25.87M |
Global Bio-chem Technology Group Co. Ltd. Technical Analysis
Negative
0.06
Price Trends
0.06
Negative
0.07
Negative
0.08
Negative
Market Momentum
<0.01
Positive
42.81
Neutral
14.29
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0809, the sentiment is Negative. The current price of 0.06 is below the 20-day moving average (MA) of 0.06, below the 50-day MA of 0.06, and below the 200-day MA of 0.08, indicating a bearish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 42.81 is Neutral, neither overbought nor oversold. The STOCH value of 14.29 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0809.
Global Bio-chem Technology Group Co. Ltd. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$325.00M | 12.59 | 5.40% | 0.78% | 5.43% | -25.42% | |
72 Outperform | HK$1.01B | 5.35 | 10.08% | 5.38% | -6.58% | 16.23% | |
70 Outperform | HK$989.78M | 3.70 | 5.08% | 10.44% | -1.19% | -9.05% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
51 Neutral | HK$40.99M | -0.17 | -18.01% | ― | 56.39% | -86.79% | |
43 Neutral | HK$791.47M | -5.08 | -1.00% | 15.38% | -4.42% | -157.03% | |
42 Neutral | HK$1.01B | -1.31 | -37.13% | ― | 42.14% | -81.25% |
* Consumer Defensive Sector Average
HK:0809
Global Bio-chem Technology Group Co. Ltd.
0.06
-0.01
-16.67%
HK:1767
TS Wonders Holding Limited
0.34
0.15
76.32%
HK:2147
Zhengwei Group Holdings Company Limited
0.63
-0.21
-25.00%
HK:2317
Vedan International (Holdings) Ltd.
0.65
0.11
20.37%
HK:3838
China Starch Holdings Limited
0.17
-0.02
-12.82%
HK:0829
Shenguan Holdings (Group) Limited
0.25
-0.01
-5.04%
Global Bio-chem Technology Group Co. Ltd. Corporate Events
Global Bio-chem Revises Corn Pricing Mechanism Under Nongfa Supply Deal
Dec 24, 2025
Global Bio-chem Technology Group Company Limited has signed a supplemental agreement with Jilin Agricultural Development Group (Nongfa) to update the pricing mechanism for corn kernels supplied under their existing master supply arrangement, which...
Global Bio-chem Elevates COO Wang Guicheng to General Manager and De Facto CEO
Dec 18, 2025
Global Bio-chem Technology Group has re-designated its chief operating officer, Mr. Wang Guicheng, as general manager with effect from 18 December 2025, as part of a broader human resources restructuring aimed at supporting the group’s futur...
Global Bio-chem Updates Nomination Committee Terms to Strengthen Governance and Diversity
Dec 18, 2025
Global Bio-chem Technology Group Company Limited has updated the terms of reference for its Board Nomination Committee, effective from 1 April 2012 and amended on 30 August 2013 and 18 December 2025. The revised document sets out the committeeR...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.